504-04-005 ISMRM Abstract

QSM Evaluates the Antifibrotic Efficacy of Bufalin and Pirfenidone in a Mouse Model of Hepatocellular Carcinoma

Primary: Preclinical Animal & in vitro MR - Small Animals

Secondary: Preclinical Animal & in vitro MR - Biology, Models, Methods

504-04-005 · Cancer Imaging and Spectroscopy · Wednesday, 13 May, 4:00 PM–5:50 PM · Ballroom East

Keywords: Hepatocellular carcinoma Fibrosis Quantitative Susceptibility Mapping (QSM) Animal mouse model

Accepted

Yongkang Ma¹, Pu-Yeh Wu², Jianqi Li³, Shuohui Yang¹

¹Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

²GE Healthcare, Beijing, China

³Shanghai Key Laboratory of Magnetic Resonance, Shanghai, China

Presenting Author: Gaiying Li

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology. 2023 May 1;77(5):1773-1796. doi: 10.1002/hep.32740. [doi]

2. Affo S, Yu LX, Schwabe RF. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol. 2017 Jan 24;12:153-186. doi: 10.1146/annurev-pathol-052016-100322. [doi]

3. Tomás-Loba A, Manieri E, González-Terán B, Mora A, Leiva-Vega L, Santamans AM, Romero-Becerra R, Rodríguez E, Pintor-Chocano A, Feixas F, López JA, Caballero B, Trakala M, Blanco Ó, Torres JL, Hernández-Cosido L, Montalvo-Romeral V, Matesanz N, Roche-Molina M, Bernal JA, Mischo H, León M, Caballero A, Miranda-Saavedra D, Ruiz-Cabello J, Nevzorova YA, Cubero FJ, Bravo J, Vázquez J, Malumbres M, Marcos M, Osuna S, Sabio G. p38γ is essential for cell cycle progression and liver tumorigenesis. Nature. 2019 Apr;568(7753):557-560. doi: 10.1038/s41586-019-1112-8. [doi]

4. Schimmel K, Jung M, Foinquinos A, José GS, Beaumont J, Bock K, Grote-Levi L, Xiao K, Bär C, Pfanne A, Just A, Zimmer K, Ngoy S, López B, Ravassa S, Samolovac S, Janssen-Peters H, Remke J, Scherf K, Dangwal S, Piccoli MT, Kleemiss F, Kreutzer FP, Kenneweg F, Leonardy J, Hobuß L, Santer L, Do QT, Geffers R, Braesen JH, Schmitz J, Brandenberger C, Müller DN, Wilck N, Kaever V, Bähre H, Batkai S, Fiedler J, Alexander KM, Wertheim BM, Fisch S, Liao R, Diez J, González A, Thum T. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction. Circulation. 2020 Mar 3;141(9):751-767. doi: 10.1161/CIRCULATIONAHA.119.042559. [doi]

5. Xie S, Qi H, Li Q, Zhang K, Zhang L, Cheng Y, Shen W. Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication. BMC Gastroenterol. 2020 Jan 15;20(1):14. doi: 10.1186/s12876-020-1161-3. [doi]

6. Luo J, He X, d'Avignon DA, Ackerman JJ, Yablonskiy DA. Protein-induced water 1H MR frequency shifts: contributions from magnetic susceptibility and exchange effects. J Magn Reson. 2010 Jan;202(1):102-8. doi: 10.1016/j.jmr.2009.10.005. [doi]

7. Li J, Lin H, Liu T, Zhang Z, Prince MR, Gillen K, Yan X, Song Q, Hua T, Zhao X, Zhang M, Zhao Y, Li G, Tang G, Yang G, Brittenham GM, Wang Y. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration. J Magn Reson Imaging. 2018 Oct;48(4):1069-1079. doi: 10.1002/jmri.26019. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/504-04-005